Document is current
Any future updates will be listed below
-
Authors
Kantor, Olga
Weiss, Anna
Burstein, Harold J.
Mittendorf, Elizabeth A.
King, Tari A. https://orcid.org/0000-0003-3602-2351
-
Funding
Funding for this research was provided by:
Ben-Liou Yao and Amy Chen
- License Information
-
More Information
Article History
Received: 14 March 2022
Accepted: 30 May 2022
First Online: 28 June 2022
Disclosure
: A.W. reports that her institution, Brigham and Women’s Hospital, has a sponsored research agreement with Myriad Laboratories, Inc. E.A.M. reports compensated service on scientific advisory boards for AstraZeneca, Exact Sciences, Merck, and Roche/Genentech; uncompensated service on steering committees for Bristol Myers Squibb, Lilly, and Roche/Genentech; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. E.A.M. reports the following nonfinancial interests and nonremunerated activities: Board of Directors for the American Society of Clinical Oncology and Scientific Advisor for Susan G. Komen for the Cure Foundation. T.A.K. reports receiving speaker’s honoraria and compensated service on the scientific Advisory Board for Exact Sciences and compensated service from Besins Healthcare Global Advisory Board outside the submitted work. The remaining authors declare no conflicts of interest.
: Institutional Quality Improvement approval was obtained prior to data review and manuscript preparation.
